Preliminary phytochemical screening and antibacterial activity of Lawsonia Inermis Linn (Henna) leaf extracts against reference bacterial strains and clinically important AMPC beta-lactamases producing Proteus mirabilis

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 1, 2013, Pages 219-222

  Jothiprakasam, Vinoth ^a   Ramesh, Samiraj ^a   Rajasekharan, Satish Kumar ^a  

^a PRIST UNIVERSITY   (India)

Author keywords

AmpC lactamases; Antimicrobial activity; Lawsonia inermis; MBC; MIC

Indexed keywords

ALKALOID; AMPICILLIN; BETA LACTAMASE; CHLORAMPHENICOL; FLAVANOID; GENTAMICIN; GLYCOSIDE; LAWSONIA INERMIS EXTRACT; PENICILLIN G; PHENOL; PLANT EXTRACT; RESIN; SAPONIN; STEROL; STREPTOMYCIN; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LAWSONIA INERMIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; VIBRIO CHOLERAE;

EID: 84874510805     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Benjar SGH. Screening for antibacterial properties of some Iranian medicinal plants against two strains of E. coli. Asian J Plant Sci 2004; 3: 310-314.
2. Finland DM, Kirby WM, Chabbert YA, Dowling HF, Garod LD, Pettinga CW et al. Are new antibiotics needed? J Antimicrob Agents Chemother 1965; 1107-1114.
3. Wealth of India, CSIR Publication 1992; 47-49.
4. Portillo A, Vila R, Freixa B, Adzet T, Canigueral S. Antifungal activity of Paraguayan plants used in traditional medicine. J Ethnopharmacol 2001; 76: 93-98.
5. Fortes TO, Alviano DS, Tupinamba G, Padron TS, Antoniolli AR, Alviano CS et al. Production of an antimicrobial substance against Cryptococcus neoformans by Paenibacillus brasilensis Sa3 isolated from the rhizosphere of Kalanchoe brasiliensis. Microbiol Res 2008; 163: 200-207.
6. Chopra RN, Chopra IC, Handa KL, Kapur LD Chopra indigenous drugs of India, 2nd ed., Calcutta: U. N Dhur and son Pvt. Ltd, 1958.
7. Carvalho PB, Ferreira EI. Leishmaniasis phytotherapy. Nature's leadership against an ancient disease-review. Fitoterapia 2001; 72: 599-618.
8. Kayser O, Kiderlen AF. In vitro leishmanicidal activity of naturally occurring chalcones. Phytother Res 2001; 1: 148.
9. Wealth of India, publications & information directory. CSIR. New Delhi, India: 1998; 164.
10. Malekzadeh F. American Society for Microbiology 1968; 16: 634-663.
11. Sastri BN. The wealth of India-Raw materials, CSIR, New Delhi: 1962; 47-50.
12. Chauhan MG, Pillai APG. Microscopic profile of powdered drug used in Indian system of Medicine, Jamnagar, Gujarat, 2007; 84-85.
13. Singh YV, Kumar S, Singh M. Agro History, Uses, Ecology and Distribution of Henna (Lawsonia Inermis) Henna Cultivation, Improvement and Trade 11-12 Jodhpur, India. Central and Arid zone Research Institute: 2005.
14. Lemordant D, Foresteier. Traditional medicinal uses and pharmacological properties of Lawsonia inermis L. Lythraceae J Agric Bot 1983; 30 supp 1: 69-89.
15. Ali GH, Bashir AK, Tanira MO. Anti inflammatory antipyretic and analgesic effect of lawsonia inermis in rats. Pharmacology 1995; 51: 356-363.
16. Chukwu OOC, Odu CE, Chukwu DI, Hafiz N, Chidozie VN, Onyimba IA. Application of extracts of Henna (Lawsonia inermis) leaves as a counter stain. Afr J Microbio Res 2011; 5 supp 21: 3351-3356.
17. Rout GR, Das S, Samontoray P, Das P. Invitro micro propagation of Lawsonia inermis (Lythraceae). Int J Trop Bisl Conserv 2001; 49: 1-7.
18. Sharma K. Tuberculosis tactic activity of henna (lawsonia inermis) Tuberderg (1990); 71: 293-295.
19. Vaidyaratnam RS. Indian Medicinal Plants. A compendium of 500 Species 1995; 3: 303-307.
20. Singh S, Shrivastava NM, Modi NT, Safi AQ. Anti-inflammatory activity of Lawsonia inermis. Current Science 1982; 519: 470-471.
21. Jain SC, Pancholi B, Jain R. In vivo and In vitro photochemical, microbial and antioxidant evaluation of sericostoma pauciflorum stocks ex wight callus. Int J Pharm Pharm Sci 2012; 4 supp 1: 332-336.
22. Trease GE, Evans WC. A Text book of Pharmcognosy, 6th Ed., Bailliere Tindall, London: 1983: 795.
23. Harborne JB. Phytochemical Method 3rd ed., 1998; 203-214.
24. NCCLS. Performance standards for antimicrobial testing. Wayne. 20th informational supplement. NCCLS; 2010; P. M100-S20.
25. Milles RS, Amyes SGB. Laboratory control of antimicrobial therapy in Mackie and McCartney Practical Medical microbiology, 14th ed., Churchill Livingstone: 1996; 151-157.
26. Dhabhai K, bhargav S, batra A. In vitro & in vivo antibacterial comparitive study in acacia nilotica. Int J Pharm Pharm Sci 2012; 4 supp 1: 174-175.
27. Prescott ML, Harley J, Donald P, Klein A. In Antimicrobial chemotherapy and microbiology 2nded., Published by C. Brown Publishers, U. S. A: 1999; 325.
28. Shahidi Bonjar GH. Evaluation of Antibacterial properties of Iranian Medicinal plant against Micrococcus aureus, Serratia marcescens, Klebsiella pneunomiae and Bordella bronchoseptica. Asian J Sci 2004; 3(1): 82-86.
29. Baker FA, Silverton RE, Pallinster CJ. Introduction to medical laboratory technology. 7th edition. 1993; 284-285.
30. Navarro F, Trallero PE, Marimon JM, Aliaga R, Gomariz M, Andmirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain. J Antimicrob Chemother 2001; 48: 383-389.